CJC-1295 w/ DAC | 5mg | Long-Acting GHRH Analog
For In Vitro Research Use Only — Not for Human or Veterinary Use
Description:
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) modified to extend the peptide’s half-life significantly. Through the inclusion of DAC, this 30-amino acid peptide remains active in circulation for several days, allowing for sustained GH release in research models. CJC-1295 w/ DAC is widely studied for its ability to promote growth hormone secretion, influence IGF-1 production, and model long-acting endocrine signaling. Provided in a 5mg lyophilized format, this compound is intended strictly for advanced laboratory-based in vitro applications.
Specifications:
-
Unit Size: 5mg (lyophilized powder, single vial)
-
Molecular Weight: ~3647.85 Da
-
Form: Lyophilized powder
- Storage: Store lyophilized peptide at 2°C–8°C in a dry, dark environment. After reconstitution, keep refrigerated between 2°C–8°C
Application Context:
CJC-1295 w/ DAC is researched for its potential influence on:
-
Pulsatile and sustained growth hormone release
-
IGF-1 elevation and endocrine regulation
-
Pituitary signaling and GH axis stimulation
-
Long-acting peptide pharmacokinetics in vitro
Intended Use:
This product is intended solely for in vitro research use. It is not approved for use in humans or animals and may not be used in food, drugs, diagnostics, or cosmetics.
Legal Disclaimer:
This product and its associated descriptions have not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding diagnosis, treatment, or prevention of any disease or condition. Use is limited to qualified professionals in licensed research settings.
Terms of Sale:
By purchasing from Golden State Peptides, the buyer confirms they are a qualified researcher or institution, fully responsible for handling, storage, and use of the product in accordance with applicable laws and regulatory requirements. All sales are final.
